查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2100338

獸醫感染疾病診斷市場－全球市場預測（2026-2032年）

Veterinary Infectious Disease Diagnostics Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫感染疾病診斷市場將成長至 43.3 億美元，複合年成長率為 8.65%。

主要市場統計數據
基準年 2025 24.2億美元
預計年份：2026年 26.2億美元
預測年份 2032 43.3億美元
複合年成長率 (%) 8.65%

獸醫感染疾病診斷在動物健康、食品安全、通用感染疾病監測和合理使用抗生素方面發揮核心作用。此領域涵蓋用於檢測伴侶動物、牲畜、家禽、養殖魚類和野生動物體內病原體（如細菌、病毒、真菌和寄生蟲）的實驗室和即時檢測工具。核心技術包括聚合酶鍊式反應(檢查室)和其他核酸增幅檢查、免疫檢測、側向層析檢測、培養和抗生素敏感性試驗、基於定序的方法、血清學以及數位病理學支持系統。寵物飼養量的增加、畜牧業生產的集約化、反覆出現的通用動物疫病、人們對人畜共患感染疾病的認知不斷提高以及動物蛋白供應鏈中日益嚴格的生物安全要求等因素，都推動了該領域的需求成長。診斷決策正日益影響治療方案的選擇、畜群管理、疫苗接種策略、移動限制和貿易合規性。因此，獸醫感染疾病診斷正在從回顧性確診轉向早期發現、基於症狀的檢測、綜合監測和實證疾病預防。

獸醫診斷領域的變革性變化

在獸醫診斷領域，一場結構性變革正在進行，從集中式的單一病原體檢測轉向更快速、多參數同步且相互關聯的診斷生態系統。分子診斷因其能夠以高分析靈敏度識別病原體、支持集體爆發確認以及在檢測方法設計和檢驗得當的情況下區分密切相關的病原體而日益重要。即時檢測正在臨床、農場、收容所和野外環境中不斷擴展，因此能夠快速分診犬小病毒、貓白血病病毒、牛呼吸道疾病病原體、禽流感和寄生蟲感染疾病等疾病。同時，實驗室正在實施自動化、檢體到結果的工作流程以及品管系統，以提高檢測結果的可重複性和報告速度。另一個重大變化是獸醫診斷與「同一健康」框架的契合。這是因為在禽流感、狂犬病、布氏桿菌症、鉤端螺旋體病、沙門氏菌病、抗生素抗藥性和媒介傳播疾病的監測中，獸醫、公共衛生、環境和食品安全等相關人員之間的合作日益重要。有關檢測檢驗、可追溯性和生物監測報告的監管要求也在影響採購決策和檢查室操作。

人工智慧在獸醫診斷領域的累積影響

人工智慧 (AI) 透過改善影像分析、疫情資訊、工作流程優先排序和決策支持，對獸醫感染疾病診斷的整體發展產生了累積影響。在診斷成像和數位顯微鏡領域，經過檢驗資料集訓練並在專家指導下使用的 AI 工具可以幫助識別寄生蟲、細胞學模式以及與病變相關的特徵。在分子診斷和定序工作流程中，機器學習可以輔助病原體分類、變異監測、引子設計評估、污染檢測以及複雜結果的解釋。 AI 在症候群監測中也變得越來越重要，它可以透過分析臨床症狀、實驗室結果、地理空間數據、天氣模式、動物遷移數據和生產指標，更早地識別異常疾病叢集。然而，AI 的實際價值取決於透明的檢驗、代表性的資料集、網路安全措施、與實驗室資訊系統的互通性以及「人機協同」的管治。最有效的應用情境不是取代獸醫或診斷專家，而是縮短獲得診斷結果的時間，提高診斷的一致性，並幫助動物衛生系統更快地應對感染疾病威脅。

獸醫感染疾病診斷的關鍵區域見解

亞太地區畜牧業規模龐大，水產養殖業蓬勃發展，家禽養殖集中化程度高，且經常接觸跨境傳染病和通用感染疾病，因此該地區對獸醫感染疾病至關重要。該地區的診斷重點包括禽流感、非洲豬瘟、口蹄疫、布氏桿菌症、寄生蟲感染疾病和水生動物疾病，並日益重視檢測能力、現場監測和疫情快速發現。北美地區受益於先進的獸醫檢測網路、完善的伴侶動物護理體系、健全的畜牧生物安全計劃以及對狂犬病、牛結核病、禽流感和抗生素耐藥性等疾病的積極監測。拉丁美洲的診斷需求與牛、家禽、豬和伴侶動物的健康密切相關，口蹄疫控制、布氏桿菌症、鉤端螺旋體病、蜱傳疾病以及出口相關衛生標準的遵守情況決定了檢測的優先順序。歐洲的特點是動物衛生法規嚴格、跨境監測完善、伴侶動物診斷技術普及率高，以及基於區域動物衛生框架的協調疾病監測。中東的重點是牲畜、馬、駱駝和家禽的診斷，優先事項包括通用感染疾病監測、進口管制、食品安全以及應對須上報動物疫病的準備工作。非洲面臨地方性和跨境動物疫病的沉重負擔，包括反芻動物鼠疫、口蹄疫、錐蟲病、狂犬病、布氏桿菌症和禽流感，因此，改善現場診斷、加強檢測實驗室建設以及整合區域監測系統尤為重要。

按戰略經濟和政策板塊進行主要群體分析

東協的獸醫診斷重點受集約化家禽和生豬養殖、水產養殖、伴侶動物成長以及禽流感、非洲豬瘟、狂犬病和水生病原體等反覆出現的威脅的影響。隨著區域內貿易和動物流動的擴大，協調統一的監測系統和提升檢查室品質變得日益重要。海灣合作理事會（GCC）國家重點關注支持糧食安全的診斷、進口動物篩檢、駱駝和通用健康管理、家禽生產以及感染疾病監測，其中檢查室現代化和快速檢測在疾病控制中發揮著至關重要的作用。歐盟擁有最完善的動物衛生體系之一，其統一的疾病通報系統、參考檢查室網路、抗菌素抗藥性監測和可追溯性要求推動了一致診斷方法的實施。金磚國家在獸醫診斷方面有著廣泛的需求，涵蓋大規模畜禽健康管理、伴侶動物檢測以及國家監測計畫等，並日益重視國內實驗室能力、分子診斷和數位化報告。七國集團（G7）國家通常擁有成熟的診斷基礎設施、強力的法律規範、較高的伴侶動物檢測利用率以及針對新發和再發動物疾病的先進監測系統。北約成員國雖然主要以安全合作為核心，但也常常重視生物安全、糧食系統韌性以及應對生物威脅的準備工作，這使得獸醫感染疾病診斷在國家和跨境風險管理中具有重要的戰略意義。

主要國家獸醫感染疾病診斷趨勢

美國擁有高度發展的獸醫診斷體系，由大學、州立、私營和聯邦實驗室組成的網路提供支持，並在伴侶動物診斷、牲畜疾病監測、禽流感監測和抗菌素抗藥性計畫方面積極開展工作。中國已擴展其獸醫診斷能力，以應對非洲豬瘟、禽流感、畜牧業集約化、水產養殖衛生管理以及日益成長的寵物護理需求。德國將先進的伴侶動物診斷與健全的牲畜和肉類動物監測系統相結合，並以歐洲動物衛生法規和嚴格的檢查室品質標準為支援。在日本的診斷環境中，重點在於高標準的檢查室、伴侶動物照護、牲畜生物安全以及對禽流感和其他法定報告疾病的防範。印度的需求取決於其大規模的牛、水牛、家禽、小型反芻動物和伴侶動物數量，重點關注領域包括口蹄疫、布氏桿菌症、狂犬病、寄生蟲感染疾病、乳腺炎病原體以及合理使用抗生素。英國擁有強大的獸醫檢測能力和疾病監測系統，專注於牛結核病、禽流感、抗生素抗藥性和伴侶動物傳染病檢查。加拿大重視對牲畜、家禽、野生動物和伴侶動物的動物健康監測，其診斷重點與生物安全、通用感染疾病控制和貿易連續性有關。俄羅斯的重點包括牲畜疾病監測、跨境疾病防範、伴侶動物檢測以及在廣大區域內建立區域檢測系統。在巴西，大規模的牛、家禽和生豬生產部門推動了與口蹄疫監測、布氏桿菌症、禽流感防範、寄生蟲疾病和出口合規性相關的診斷需求。在義大利、法國和西班牙，健全的伴侶動物照護與牲畜和肉類動物的監測相平衡，並得到歐洲法定傳染病系統、抗菌素抗藥性監測和檢查室品質要求的支持。墨西哥的診斷環境受到牲畜健康、伴侶動物照護、家禽生產、狂犬病控制、布氏桿菌症以及跨國衛生要求的影響。澳洲擁有強大的生物安全管治和監測能力，其診斷重點涵蓋牲畜、野生動物、伴侶動物以及預防外來疾病傳入。韓國擁有先進的獸醫診斷基礎設施，專注於伴侶動物健康、家禽和豬病監測、禽流感、非洲豬瘟以及國家級生物安全體系的建設。

為獸醫診斷領域的領導者提供的實用建議

產業領導者應優先考慮經過驗證且目標明確的診斷解決方案，這些方案應與臨床決策、檢驗要求和現場條件相符。多重PCR、快速抗原檢測、血清學檢測、抗菌藥物敏感性檢測和定序的投資必須輔以清晰的品質保證、檢體物流和結果解讀流程。診斷服務提供者和動物健康相關人員應加強實驗室資訊系統、獸醫實踐平台、畜群管理軟體和監測資料庫之間的互通性，以加快報告和流行病學分析。各組織還應在設計產品和服務時考慮可操作性，包括強大的即時檢測模式、低溫運輸相容試劑、簡化的樣本製備流程和多語言培訓資源。對於人工智慧驅動的診斷技術，領導者應在廣泛部署之前建立檢驗標準、偏差監測、資料管治和臨床醫生監督機制。與獸醫學院、參考檢測實驗室、生產者協會、公共衛生機構和食品安全監管機構夥伴關係，有助於推廣應用，同時支持「同一健康」理念的實現。最後，市場參與企業應該透過科學信譽、監管應對力、技術支援以及證明其診斷技術能夠改善動物福利、治療準確性、疫情應對和生物安全績效的證據來脫穎而出。

調查方法

本執行摘要基於系統的二手研究方法，參考了公開且檢驗的資訊來源，包括動物衛生機構出版刊物、獸醫流行病學文獻、同行評審期刊、監管指南、疾病監測報告、診斷檢驗研究途徑以及經認證的「同一健康」相關資料。分析考察了伴侶動物、牲畜、家禽、水產養殖、馬匹健康和野生動物檢驗等領域的技術應用趨勢、區域疾病控制重點、政策框架、檢查室基礎設施和臨床應用案例。報告整合了研究結果，但未進行市場規模計算、市場佔有率估算或未來預測。重點關注循證趨勢，包括已記錄的疾病負擔、監測重點、檢測方法的演變、監管預期以及獲得診斷的實際障礙。調查方法也採用了定性檢驗測量法，比較多個可靠資訊來源，從而減少對單一觀點的過度依賴，並確保結論反映實際的獸醫診斷實踐。

結論

獸醫感染疾病診斷如今已成為動物健康體系的基石，為早期發現、標靶治療、疾病預防以及跨部門的「同一健康」監測提供支持。分子檢測、快速即時診斷、數位連接、定序以及精心管理的人工智慧正在重塑這一領域。儘管各地需求差異顯著，但通用的優先事項包括快速應對疫情、驗證可靠檢測方法、改善現場檢測管道、合理使用抗生素以及將獸醫數據整合到更廣泛的健康安全框架中。具備科學嚴謹性和實用性、符合監管要求並擁有強大數位化基礎設施的機構將更有能力為獸醫、生產者、實驗室和公共機構提供支援。隨著感染疾病風險持續影響伴侶動物、家畜、野生動物和全球糧食系統，診斷技術對於增強抵抗能力、保障生物安全和提供實證動物照護仍然至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 獸醫感染疾病診斷市場：依疾病類別分類

  • 細菌
  • 真菌
  • 寄生
  • 病毒性的

第8章：獸醫感染疾病診斷市場：依產品分類

  • 消耗品
    • 試劑
    • 檢測套組
  • 設備/分析儀
    • 臨床化學分析儀
    • 血液分析儀
    • 免疫診斷分析儀
    • 分子診斷分析儀

第9章：獸醫感染疾病診斷市場：依產品/服務分類

  • 硬體
  • 服務
  • 軟體

第10章：獸醫感染疾病診斷市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 牲畜/生產動物
    • 牛
    • 山羊
    • 家禽
    • 羊
    • 豬

第11章：獸醫感染疾病診斷市場：依最終用途分類

  • 院內檢測設施
    • 動物收容所
    • 寵物飼主
  • 研究所
  • 獸醫醫院和診所

第12章 獸醫感染疾病診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸醫感染疾病診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫感染疾病診斷市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 日本
  • 印度
  • 英國
  • 加拿大
  • 俄羅斯
  • 巴西
  • 義大利
  • 墨西哥
  • 法國
  • 西班牙
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agrolabo SpA
  • Antech Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biogal Galed Labs
  • BioMerieux SA
  • BioNote, Inc.
  • Demeditec Diagnostics GmbH
  • DEXX Laboratories Inc.
  • Eurofins Technologies
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Mars, Incorporated
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nisseiken Co., Ltd
  • Qiagen NV
  • Randox Laboratories, Ltd.
  • Shenzhen Bioeasy Biotechnology Co., Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • SKYER, Inc.
  • Skyla Corporation
  • Thermo Fisher Scientific Inc.
  • Vimian Group AB
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-742BD5184F0A

The Veterinary Infectious Disease Diagnostics Market is projected to grow by USD 4.33 billion at a CAGR of 8.65% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.62 billion
Forecast Year [2032] USD 4.33 billion
CAGR (%) 8.65%

Veterinary infectious disease diagnostics are becoming central to animal health, food security, zoonotic disease surveillance, and antimicrobial stewardship. The field covers laboratory and point-of-care tools used to detect bacterial, viral, fungal, and parasitic pathogens in companion animals, livestock, poultry, aquaculture species, and wildlife. Core technologies include PCR and other nucleic acid amplification tests, immunoassays, lateral flow tests, culture and antimicrobial susceptibility testing, sequencing-based methods, serology, and digital pathology support systems. Demand is shaped by well-documented drivers, including rising pet ownership, intensifying livestock production, recurring transboundary animal diseases, increased awareness of zoonoses, and stricter biosecurity expectations across animal protein supply chains. Diagnostic decisions increasingly influence treatment selection, herd management, vaccination strategies, movement controls, and trade compliance. As a result, veterinary infectious disease diagnostics are shifting from reactive confirmation toward earlier detection, syndromic testing, integrated surveillance, and evidence-based disease prevention.

Transformative Shifts in the Veterinary Diagnostics Landscape

The veterinary diagnostics landscape is undergoing a structural shift from centralized, single-pathogen testing toward faster, multiplexed, and connected diagnostic ecosystems. Molecular diagnostics are gaining prominence because they can identify pathogens with high analytical sensitivity, support outbreak confirmation, and differentiate closely related agents when assays are well designed and validated. Point-of-care testing is expanding in clinics, farms, shelters, and field settings, enabling faster triage for diseases such as canine parvovirus, feline leukemia virus, bovine respiratory disease pathogens, avian influenza, and parasitic infections. At the same time, laboratories are adopting automation, sample-to-answer workflows, and quality management systems to improve reproducibility and turnaround time. Another major shift is the alignment of veterinary diagnostics with One Health frameworks, as surveillance for avian influenza, rabies, brucellosis, leptospirosis, salmonellosis, antimicrobial resistance, and vector-borne diseases increasingly requires coordination among veterinary, public health, environmental, and food safety stakeholders. Regulatory expectations for test validation, traceability, and biosurveillance reporting are also influencing procurement decisions and laboratory practices.

Cumulative Impact of Artificial Intelligence on Veterinary Diagnostics

Artificial intelligence is creating cumulative impact across veterinary infectious disease diagnostics by improving image analysis, outbreak intelligence, workflow prioritization, and decision support. In diagnostic imaging and digital microscopy, AI-enabled tools can assist with recognition of parasites, cytology patterns, and lesion-associated features when trained on validated datasets and used under professional oversight. In molecular and sequencing workflows, machine learning can support pathogen classification, variant monitoring, primer design assessment, contamination flagging, and interpretation of complex results. AI is also increasingly relevant for syndromic surveillance, where clinical signs, laboratory results, geospatial signals, weather patterns, animal movement data, and production metrics can be analyzed to identify abnormal disease clusters earlier. However, the practical value of AI depends on transparent validation, representative datasets, cybersecurity controls, interoperability with laboratory information systems, and human-in-the-loop governance. The strongest use cases are not replacing veterinarians or diagnosticians, but reducing time to insight, improving consistency, and helping animal health systems respond more rapidly to infectious disease threats.

Key Regional Insights for Veterinary Infectious Disease Diagnostics

Asia-Pacific is a critical region for veterinary infectious disease diagnostics because of its large livestock populations, major aquaculture activity, dense poultry production, and recurring exposure to transboundary and zoonotic diseases. Diagnostic priorities in the region include avian influenza, African swine fever, foot-and-mouth disease, brucellosis, parasitic infections, and aquatic animal diseases, with increasing emphasis on laboratory capacity, field surveillance, and rapid outbreak confirmation. North America benefits from advanced veterinary laboratory networks, established companion animal care pathways, strong livestock biosecurity programs, and active surveillance for diseases such as rabies, bovine tuberculosis, avian influenza, and antimicrobial resistance. Latin America's diagnostic needs are closely linked to cattle, poultry, swine, and companion animal health, with foot-and-mouth disease control, brucellosis, leptospirosis, tick-borne disease, and export-related sanitary compliance shaping testing priorities. Europe is characterized by strict animal health regulations, cross-border surveillance, high companion animal diagnostic adoption, and coordinated disease monitoring under regional animal health frameworks. The Middle East places emphasis on livestock, equine, camel, and poultry diagnostics, with priorities including zoonotic disease surveillance, import controls, food security, and preparedness for notifiable animal diseases. Africa faces a high burden of endemic and transboundary animal diseases, including peste des petits ruminants, foot-and-mouth disease, trypanosomiasis, rabies, brucellosis, and avian influenza, making accessible field diagnostics, laboratory strengthening, and regional surveillance integration especially important.

Key Group Insights Across Strategic Economic and Policy Blocs

ASEAN's veterinary diagnostic priorities are shaped by intensive poultry and swine production, aquaculture, companion animal growth, and recurring threats such as avian influenza, African swine fever, rabies, and aquatic pathogens. Harmonized surveillance and laboratory quality improvement are increasingly important as intra-regional trade and animal movement expand. GCC countries focus on diagnostics that support food security, imported animal screening, camel and equine health, poultry production, and zoonotic disease monitoring, with laboratory modernization and rapid testing playing key roles in disease preparedness. The European Union maintains one of the most structured animal health environments, with harmonized disease notification, reference laboratory networks, antimicrobial resistance monitoring, and traceability requirements driving consistent diagnostic adoption. BRICS countries collectively represent diverse veterinary diagnostic needs, from large-scale livestock and poultry health management to companion animal testing and national surveillance programs, with growing emphasis on domestic laboratory capacity, molecular diagnostics, and digital reporting. G7 countries generally demonstrate mature diagnostic infrastructure, strong regulatory oversight, high companion animal testing utilization, and advanced surveillance systems for emerging and re-emerging animal diseases. NATO member countries, while primarily defined by security cooperation, often emphasize biosecurity, resilience of food systems, and preparedness for biological threats, reinforcing the strategic relevance of veterinary infectious disease diagnostics in national and cross-border risk management.

Key Country Insights for Veterinary Infectious Disease Diagnostics

The United States has a highly developed veterinary diagnostic ecosystem supported by university, state, private, and federal laboratory networks, with strong activity in companion animal diagnostics, livestock disease surveillance, avian influenza monitoring, and antimicrobial resistance programs. China has expanded veterinary diagnostic capacity in response to African swine fever, avian influenza, livestock intensification, aquaculture health, and growing pet care demand. Germany combines advanced companion animal diagnostics with robust livestock and food animal surveillance, supported by European animal health regulations and strong laboratory quality standards. Japan's diagnostic environment emphasizes high laboratory standards, companion animal care, livestock biosecurity, and preparedness for avian influenza and other notifiable diseases. India's needs are shaped by large cattle, buffalo, poultry, small ruminant, and companion animal populations, with key focus areas including foot-and-mouth disease, brucellosis, rabies, parasitic infections, mastitis pathogens, and antimicrobial stewardship. The United Kingdom maintains strong veterinary laboratory capability and disease surveillance, with attention to bovine tuberculosis, avian influenza, antimicrobial resistance, and companion animal infectious disease testing. Canada emphasizes animal health surveillance across livestock, poultry, wildlife, and companion animals, with diagnostic priorities linked to biosecurity, zoonotic disease control, and trade continuity. Russia's priorities include livestock disease surveillance, transboundary disease preparedness, companion animal testing, and regional laboratory coverage across a large geography. Brazil's extensive cattle, poultry, and swine sectors drive demand for diagnostics related to foot-and-mouth disease surveillance, brucellosis, avian influenza preparedness, parasitic disease, and export compliance. Italy, France, and Spain pair strong companion animal care with livestock and food animal surveillance, supported by European notifiable disease systems, antimicrobial resistance monitoring, and laboratory quality requirements. Mexico's diagnostic landscape is influenced by livestock health, companion animal care, poultry production, rabies control, brucellosis, and cross-border sanitary requirements. Australia benefits from strong biosecurity governance and surveillance capabilities, with diagnostic priorities spanning livestock, wildlife, companion animals, and exotic disease exclusion. South Korea has advanced veterinary diagnostic infrastructure focused on companion animal health, poultry and swine disease monitoring, avian influenza, African swine fever, and national biosecurity readiness.

Actionable Recommendations for Veterinary Diagnostics Leaders

Industry leaders should prioritize validated, fit-for-purpose diagnostic solutions that align with clinical decision-making, surveillance requirements, and field conditions. Investment in multiplex PCR, rapid antigen testing, serology, antimicrobial susceptibility testing, and sequencing should be matched with clear quality assurance, sample logistics, and result interpretation protocols. Diagnostic providers and animal health stakeholders should strengthen interoperability between laboratory information systems, veterinary practice platforms, herd management software, and surveillance databases to accelerate reporting and epidemiological analysis. Organizations should also design products and services for practical deployment, including rugged point-of-care formats, cold-chain-conscious reagents, simplified sample preparation, and multilingual training resources. For AI-enabled diagnostics, leaders should establish validation standards, bias monitoring, data governance, and clinician oversight before broad deployment. Partnerships with veterinary schools, reference laboratories, producer groups, public health agencies, and food safety authorities can improve adoption while supporting One Health outcomes. Finally, market participants should differentiate through scientific credibility, regulatory readiness, technical support, and evidence that diagnostics improve animal welfare, treatment precision, outbreak response, and biosecurity performance.

Research Methodology

This executive summary is developed using a structured secondary research approach grounded in publicly available and verifiable sources, including animal health authority publications, veterinary epidemiology literature, peer-reviewed journals, regulatory guidance, disease surveillance reports, diagnostic validation standards, and recognized One Health resources. The analysis reviews technology adoption trends, regional disease priorities, policy frameworks, laboratory infrastructure, and clinical use cases across companion animals, livestock, poultry, aquaculture, equine health, and wildlife surveillance. Insights are synthesized without market sizing, market share estimation, or forecasting. Emphasis is placed on evidence-backed patterns such as documented disease burdens, surveillance priorities, test modality evolution, regulatory expectations, and practical barriers to diagnostic access. The methodology also applies qualitative triangulation, comparing multiple credible source categories to reduce overreliance on a single viewpoint and to ensure that conclusions reflect real-world veterinary diagnostic practice.

Conclusion

Veterinary infectious disease diagnostics are now a foundational component of animal health systems, supporting early detection, targeted treatment, disease prevention, and cross-sector One Health surveillance. The sector is being reshaped by molecular testing, rapid point-of-care diagnostics, digital connectivity, sequencing, and carefully governed artificial intelligence. Regional needs differ substantially, but common priorities include faster outbreak response, reliable test validation, improved access in field settings, antimicrobial stewardship, and integration of veterinary data into broader health security frameworks. Organizations that combine scientific rigor with practical usability, regulatory alignment, and strong digital infrastructure will be best positioned to support veterinarians, producers, laboratories, and public agencies. As infectious disease risks continue to affect companion animals, livestock, wildlife, and global food systems, diagnostics will remain essential to resilience, biosecurity, and evidence-based animal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Infectious Disease Diagnostics Market, by Disease Category

  • 7.1. Introduction
  • 7.2. Bacterial
  • 7.3. Fungal
  • 7.4. Parasitic
  • 7.5. Viral

8. Veterinary Infectious Disease Diagnostics Market, by Product

  • 8.1. Introduction
  • 8.2. Consumables
    • 8.2.1. Reagents
    • 8.2.2. Test kits
  • 8.3. Instruments/Analyzers
    • 8.3.1. Clinical chemistry analyzers
    • 8.3.2. Hematology analyzers
    • 8.3.3. Immunodiagnostic analyzers
    • 8.3.4. Molecular diagnostic analyzers

9. Veterinary Infectious Disease Diagnostics Market, by Offering

  • 9.1. Introduction
  • 9.2. Hardware
  • 9.3. Services
  • 9.4. Software

10. Veterinary Infectious Disease Diagnostics Market, by Animal Type

  • 10.1. Introduction
  • 10.2. Companion Animals
    • 10.2.1. Cat
    • 10.2.2. Dog
  • 10.3. Livestock/Production Animals
    • 10.3.1. Cattle
    • 10.3.2. Goats
    • 10.3.3. Poultry
    • 10.3.4. Sheep
    • 10.3.5. Swine

11. Veterinary Infectious Disease Diagnostics Market, by End Use

  • 11.1. Introduction
  • 11.2. In-House Testing Facilities
    • 11.2.1. Animal Shelters
    • 11.2.2. Pet Owners
  • 11.3. Research Laboratories
  • 11.4. Veterinary Hospitals & Clinics

12. Veterinary Infectious Disease Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Veterinary Infectious Disease Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Infectious Disease Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. China
  • 14.3. Germany
  • 14.4. Japan
  • 14.5. India
  • 14.6. United Kingdom
  • 14.7. Canada
  • 14.8. Russia
  • 14.9. Brazil
  • 14.10. Italy
  • 14.11. Mexico
  • 14.12. France
  • 14.13. Spain
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agrolabo S.p.A.
  • 16.2. Antech Diagnostics, Inc.
  • 16.3. Bio-Rad Laboratories, Inc.
  • 16.4. Biogal Galed Labs
  • 16.5. BioMerieux S.A.
  • 16.6. BioNote, Inc.
  • 16.7. Demeditec Diagnostics GmbH
  • 16.8. DEXX Laboratories Inc.
  • 16.9. Eurofins Technologies
  • 16.10. Fassisi GmbH
  • 16.11. FUJIFILM Holdings Corporation
  • 16.12. IDEXX Laboratories, Inc.
  • 16.13. IDvet
  • 16.14. Mars, Incorporated
  • 16.15. Merck & Co., Inc.
  • 16.16. Neogen Corporation
  • 16.17. Nisseiken Co., Ltd
  • 16.18. Qiagen N.V.
  • 16.19. Randox Laboratories, Ltd.
  • 16.20. Shenzhen Bioeasy Biotechnology Co., Ltd.
  • 16.21. Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • 16.22. SKYER, Inc.
  • 16.23. Skyla Corporation
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Vimian Group AB
  • 16.26. Virbac S.A.
  • 16.27. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FUNGAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FUNGAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FUNGAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARASITIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARASITIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARASITIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VIRAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INSTRUMENTS/ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL CHEMISTRY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEMATOLOGY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMMUNODIAGNOSTIC ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MOLECULAR DIAGNOSTIC ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HARDWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HARDWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HARDWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CAT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CAT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DOG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DOG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DOG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIVESTOCK/PRODUCTION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIVESTOCK/PRODUCTION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIVESTOCK/PRODUCTION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SHEEP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SHEEP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SHEEP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IN-HOUSE TESTING FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL SHELTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 174. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 178. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 179. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 180. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 183. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 184. GCC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 207. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 209. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 210. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 211. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 212. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 213. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 216. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 218. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 223. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 224. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 228. NATO VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 260. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 261. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 262. GERMANY VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 263. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 265. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 266. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 268. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 269. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 271. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 272. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 274. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 278. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 279. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 280. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 282. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 284. INDIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 296. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS/ANALYZERS, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY LIVESTOCK/PRODUCTION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, BY IN-HOUSE TESTING FACILITIES, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE